Centre for Urological Research

Commercial activities

Novogen Limited, Sydney, Australia
Contract research completed with Novogen Limited investigated the effects of dietary isoflavones on the prostate gland. Pre-clinical trials have utilised the Centre for Urological Research drug screening technology and animal models. Phase I clinical trials, both an efficacy and intervention study, have been completed in human prostate cancer patients.

Schering AG, Berlin, Germany
Contract research is ongoing with Schering AG.